BC
PGNX
Broadfin Capital’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $15.6M | Buy |
3,060,923
+1,476,998
| +93% | +$7.52M | 2.09% | 10 |
|
|
2019
Q3 | $8.01M | Buy |
+1,583,925
| New | +$8.01M | 1.48% | 16 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 61 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 57 |
|
|
2017
Q3 | – | Sell |
-1,000,000
| Closed | -$6.79M | – | 51 |
|
|
2017
Q2 | $6.79M | Sell |
1,000,000
-998,531
| -50% | -$6.78M | 0.82% | 27 |
|
|
2017
Q1 | $18.9M | Sell |
1,998,531
-6,952,638
| -78% | -$65.6M | 2.29% | 13 |
|
|
2016
Q4 | $77.3M | Hold |
8,951,169
| – | – | 8.59% | 2 |
|
|
2016
Q3 | $56.7M | Hold |
8,951,169
| – | – | 5.08% | 4 |
|
|
2016
Q2 | $37.8M | Hold |
8,951,169
| – | – | 3.67% | 6 |
|
|
2016
Q1 | $39M | Hold |
8,951,169
| – | – | 3.77% | 5 |
|
|
2015
Q4 | $54.9M | Hold |
8,951,169
| – | – | 3.38% | 6 |
|
|
2015
Q3 | $51.2M | Hold |
8,951,169
| – | – | 2.85% | 5 |
|
|
2015
Q2 | $66.8M | Hold |
8,951,169
| – | – | 3.59% | 5 |
|
|
2015
Q1 | $53.5M | Hold |
8,951,169
| – | – | 4.17% | 5 |
|
|
2014
Q4 | $67.7M | Hold |
8,951,169
| – | – | 5.88% | 3 |
|
|
2014
Q3 | $46.5M | Buy |
8,951,169
+2,315,000
| +35% | +$12M | 4.87% | 4 |
|
|
2014
Q2 | $28.6M | Buy |
6,636,169
+1,050,000
| +19% | +$4.53M | 2.79% | 9 |
|
|
2014
Q1 | $22.8M | Buy |
5,586,169
+1,586,169
| +40% | +$6.49M | 2.21% | 11 |
|
|
2013
Q4 | $21.3M | Buy |
4,000,000
+520,652
| +15% | +$2.78M | 2.81% | 12 |
|
|
2013
Q3 | $17.5M | Sell |
3,479,348
-21,267
| -0.6% | -$107K | 3.1% | 12 |
|
|
2013
Q2 | $15.6M | Buy |
+3,500,615
| New | +$15.6M | 3.05% | 12 |
|